KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Liabilities and Shareholders Equity (2018 - 2025)

Historic Liabilities and Shareholders Equity for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $60.4 million.

  • ClearPoint Neuro's Liabilities and Shareholders Equity rose 5016.79% to $60.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $192.5 million, marking a year-over-year increase of 180.89%. This contributed to the annual value of $39.2 million for FY2024, which is 813.86% down from last year.
  • Per ClearPoint Neuro's latest filing, its Liabilities and Shareholders Equity stood at $60.4 million for Q3 2025, which was up 5016.79% from $62.9 million recorded in Q2 2025.
  • ClearPoint Neuro's Liabilities and Shareholders Equity's 5-year high stood at $74.3 million during Q1 2021, with a 5-year trough of $30.1 million in Q1 2025.
  • In the last 5 years, ClearPoint Neuro's Liabilities and Shareholders Equity had a median value of $54.6 million in 2022 and averaged $53.9 million.
  • As far as peak fluctuations go, ClearPoint Neuro's Liabilities and Shareholders Equity skyrocketed by 21486.95% in 2021, and later crashed by 4393.8% in 2025.
  • Over the past 5 years, ClearPoint Neuro's Liabilities and Shareholders Equity (Quarter) stood at $65.6 million in 2021, then decreased by 15.39% to $55.5 million in 2022, then fell by 23.12% to $42.7 million in 2023, then fell by 8.14% to $39.2 million in 2024, then skyrocketed by 54.02% to $60.4 million in 2025.
  • Its last three reported values are $60.4 million in Q3 2025, $62.9 million for Q2 2025, and $30.1 million during Q1 2025.